Skip to content

OS THERAPIES INCORPORATED

OSTX

CIK 0001795091

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$25.69M
−223.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.85
+23.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$917.55K
Q1 May 2026
Total Debt
$250K
Q1 May 2026
Shares Outstanding
44.54M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings